A total of 1695 patients were enrolled of which 49.5 % received intravenous steroids for treatment of septic shock at baseline ( DrotAA + steroids N = 436 ; DrotAA + no steroids N = 414 ; placebo + steroids N = 403 ; placebo + no steroids N = 442 ) .